• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,092
79
60
57
46

COUNTRY

55
19
8
6
5

CATEGORIES

  • 89
  • 128
  • 71
  • 72
  • 44
  • 43
  • 21
  • 16
  • 20
  • 22

PRICE

550
801
1,599
2,561

PUBLISHED

145
291
750
2,561

PRODUCT TYPE

2,413
74
61
12
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Hairy Cell Leukemia Global Clinical Trials Review, H1, 2014

Hairy Cell Leukemia Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Hairy Cell Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Hairy Cell Leukemia...

February 2014
FROM

Bladder Cancer - Pipeline Review, H1 2014

Bladder Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2014’, provides an overview of the Bladder Cancer’s therapeutic pipeline. This report...

February 2014
FROM

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s...

February 2014
FROM

Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2014

Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Diffuse Large B-Cell...

February 2014
FROM

Metastatic Liver Cancer - Pipeline Review, H1 2014

Metastatic Liver Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Liver Cancer - Pipeline Review, H1 2014’, provides an overview of the Metastatic Liver Cancer’s therapeutic...

February 2014
FROM

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2014

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2014’, provides an overview of the Peripheral...

February 2014
FROM

Metastatic Pancreatic Cancer - Pipeline Review, H1 2014

Metastatic Pancreatic Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2014’, provides an overview of the Metastatic Pancreatic...

February 2014
FROM

Malignant Mesothelioma - Pipeline Review, H1 2014

Malignant Mesothelioma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H1 2014’, provides an overview of the Malignant Mesothelioma’s therapeutic...

February 2014
FROM

Endometrial Cancer - Pipeline Review, H1 2014

Endometrial Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Endometrial Cancer - Pipeline Review, H1 2014’, provides an overview of the Endometrial Cancer’s therapeutic pipeline. This...

February 2014
FROM

Nasopharyngeal Cancer - Pipeline Review, H1 2014

Nasopharyngeal Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Nasopharyngeal Cancer - Pipeline Review, H1 2014’, provides an overview of the Nasopharyngeal Cancer’s therapeutic...

February 2014
FROM

Myelodysplastic Syndrome - Pipeline Review, H1 2014

Myelodysplastic Syndrome - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2014’, provides an overview of the Myelodysplastic Syndrome’s therapeutic...

February 2014
FROM

Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2014

Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the...

February 2014
FROM

Hypopharyngeal Cancer Global Clinical Trials Review, H1, 2014

Hypopharyngeal Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Hypopharyngeal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Hypopharyngeal...

February 2014
FROM

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review,...

February 2014
FROM

Hodgkin Lymphoma - Pipeline Review, H1 2014

Hodgkin Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hodgkin Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Hodgkin Lymphoma’s therapeutic pipeline. This...

February 2014
FROM

Anaplastic Astrocytoma - Pipeline Review, H1 2014

Anaplastic Astrocytoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Anaplastic Astrocytoma - Pipeline Review, H1 2014’, provides an overview of the Anaplastic Astrocytoma’s therapeutic...

February 2014
FROM

Rectal Cancer - Pipeline Review, H1 2014

Rectal Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Rectal Cancer - Pipeline Review, H1 2014’, provides an overview of the Rectal Cancer’s therapeutic pipeline. This report...

February 2014
FROM

Medullary Thyroid Cancer - Pipeline Review, H1 2014

Medullary Thyroid Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Medullary Thyroid Cancer - Pipeline Review, H1 2014’, provides an overview of the Medullary Thyroid Cancer’s therapeutic...

February 2014
FROM

Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014

Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014’, provides an overview of the Gastrointestinal...

February 2014
FROM

Mantle Cell Lymphoma - Pipeline Review, H1 2014

Mantle Cell Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline. This...

February 2014
FROM
Loading Indicator

Our Clients

Our clients' logos